Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163614 · ClinicalTrials.gov registry record · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
A NA study of Hypertension and End Stage Renal Disease, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT04163614 is a NA study of Hypertension and End Stage Renal Disease that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 69 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04163614, a NA study of Hypertension and End Stage Renal Disease, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizations, and excessive body fluid is a major cause of this. While empiric aggressive fluid removal during dialysis is one approach to limit fluid overload, this can cause dangerous decreases in blood pressure during dialysis that independently contribute to the high death rate. In this study, I aim to test a new strategy that prescribes fluid removal based on a patient's recent blood pressure patterns during dialysis. This clinical trial will compare my strategy to standard care and assess the outcomes of overall blood pressure change between dialysis treatments in addition to the number of times the blood pressure becomes dangerously low during dialysis. Another aim is to determine how differences in the structure and function of the heart influence blood pressure during dialysis.
Conditions Studied
Interventions
- OTHER IBPS-Guided Ultrafiltration
Study Locations (1)
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04163614
The ClinicalTrials.gov registry entry for NCT04163614 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which IBPS-Guided Ultrafiltration is the first listed.
NCT04163614 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04163614 about?
NCT04163614 is a clinical study titled "Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients". Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizati...
What is the current status of trial NCT04163614?
This trial is currently recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2021-02-10. Estimated completion is 2026-07-01.
What conditions does trial NCT04163614 study?
This clinical trial studies the following conditions: Hypertension, End Stage Renal Disease, Intradialytic Hypotension, Extracellular Volume Overload.
What interventions are being tested in trial NCT04163614?
The interventions under investigation include: IBPS-Guided Ultrafiltration (OTHER).
Who is sponsoring clinical trial NCT04163614?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04163614 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.